CV vs ECL
CapsoVision, Inc. Common Stock (CV) versus Ecolab Inc (ECL) — a side-by-side from cached financials, not a winner call.
CapsoVision, Inc. Common Stock (CV) is a medical devices company listed on US.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Latest reported CV revenue for 2025-09-30 was $3.5M. Net income was -$7.9M. Revenue was up 6.7% from 2025-06-30 to 2025-09-30. CV currently screens at market cap $359.2M.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
CV currently screens at market cap $359.2M. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Not investment advice. Open the CV and ECL stock pages for the full models.
Not investment advice.